InsiderDB

SEC EDGAR · Company announcement

CVS: Financial results

Filed 8-K for an event or period dated 2026-08-05. Financial results.

Follow CVS
Became public
Aug 5, 2026, 6:32 AM EDT
Event / period date
Aug 5, 2026
Collected
Nov 9, 2026, 12:17 PM EST

Why this is connected

This filing identifies CVS HEALTH Corp as the issuer of the security. The company's SEC identifier connects it to CVS.

Press Release of CVS Health Corporation dated August 5, 2026 (furnished under Item 2.02). ↗

Source evidence

Read the source excerpt or record
Item 2.02 Results of Operations and Financial Condition. On August 5, 2026 , CVS Health Corporation issued a press release announcing results for the three months ended June 30, 2026. A copy of that press release is furnished herewith as Exhibit 99.1 and hereby incorporated in this Item 2.02 by reference. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the liabilities of that Section, and shall not be or be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing. Section 9 - Financial Statements and Exhibits Item 9.01 Financial Statements and Exhibits. (d) Exhibits . The exhibits to this Current Report on Form 8-K are as follows: INDEX TO EXHIBITS 99.1 Press Release of CVS Health Corporation dated August 5, 2026 (furnished under Item 2.02). 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CVS HEALTH CORPORATION Date: August 5, 2026 By: /s/ Brian O. Newman Brian O. Newman Executive Vice President and Chief Financial Officer

Price change after we could observe it

+0.57% CVS

Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.

Congressional trading in CVS

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.